Abstract:Background: Updated prevalence estimates along the continuum of Alzheimer's disease (AD) can foster a more nuanced and effective approach to managing AD within the current healthcare landscape. Objectives: This study aims to estimate the prevalence and severity distribution of dementia/AD (including mild, moderate, and severe stages) and all-cause mild cognitive impairment (MCI) in the United States using data from the Health and Retirement Study (HRS). Design: Retrospective study. Setting: Data from the bi-annual HRS surveys involving in-depth interviews of a representative sample of Americans aged >50 years. Participants: Dementia/AD and all-cause MCI patients from the 4 most recent HRS surveys (2014, 2016, 2018 and 2020). Measurements: AD was identified based on diagnosis (self-report). Cognitive performance (modified Telephone Interview of Cognitive Status [TICS-m]) scores in the dementia/AD range were also captured; all-cause MCI was similarly identified using the TICS-m. Dementia/AD and MCI prevalence, as well as the distribution by dementia/AD stage (mild, moderate, or severe), were estimated. Sampling weights developed by HRS were applied to ensure the sample's representativeness of the target population and unbiased estimates for population parameters. Results: Across the four HRS surveys, the total number of HRS respondents ranged from 15,000 to 21,000 (unweighted); 7,000 to 14,000 had TICS-m scores. The estimated prevalence of AD (all severity categories combined) in the 2014, 2016, 2018, and 2020 HRS surveys was 1.2%, 1.2%, 1.3% and 1.0%, respectively using the diagnosis-based approach; using the cognitive performance-based approach, 23-27% patients had scores in the dementia/AD ranges across the 4 surveys. The estimated prevalence of all-cause MCI was consistently 23% in each survey. In the 2020 survey, the distribution of mild, moderate, and severe disease stages was 34%, 45%, and 21%, respectively, in patients self-reporting an AD diagnosis, and 55%, 40%, and 5%, respectively in all patients meeting TICS-m threshold for dementia/AD. Conclusion: The prevalence of AD diagnosis based on self-report was approximately 1% across the 4 most recent HRS surveys and may reflect the proportion of patients who have actively sought healthcare for AD. Among HRS survey respondents with cognitive scores available, over 20% were in the dementia/AD range. The distribution of disease by stage differed for self-reported AD diagnosis vs dementia/AD based on cognitive scores. Discordance in estimates of dementia/AD and stage distributions underscores a need for better understanding of clinical practice patterns in AD diagnosis, use of clinical assessment tools, and severity classification in the United States. Accurate patient identification is needed, especially early in the AD disease continuum, to allow for timely and appropriate initiation of new anti-amyloid treatments.

The Impact of Methods to Handle Missing Data on the Estimated Prevalence of Dementia and Mild Cognitive Impairment in a Cross-Sectional Study Including Non-Responders.

Sociodemographic Factors Predict Incident Mild Cognitive Impairment: A Brief Review and Empirical Study.

Robust Estimation of Dementia Prevalence from Two-Phase Surveys with Non-Responders Via Propensity Score Stratification

Modeling of Correlated Cognitive Function and Functional Disability Outcomes with Bounded and Missing Data in a Longitudinal Aging Study

The Prevalence Of Mild Cognitive Impairment In China: A Systematic Review

Discriminant Validity and Time‐effectiveness of A Stepwise Dementia Case‐finding Approach in an Asian Elderly Community

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

A1362 Bayesian Estimation on Diagnostic Performance of Dementia Screening Tests in the Absence of a Gold Standard

Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States

Prevalence of Dementia and the Attributable Contributions of Modifiable Risk Factors in China.

Cost-benefit and Discriminant Validity of a Stepwise Dementia Case-Finding Approach in an Asian Older Adult Community

Dealing with missing data in multi-informant studies: A comparison of approaches

Comparison of Prevalence and Associated Risk Factors of Cognitive Function Status among Elderly Between Nursing Homes and Common Communities of China A STROBE-compliant Observational Study

Balancing efficacy and computational burden: weighted mean, multiple imputation, and inverse probability weighting methods for item non-response in reliable scales

Use of the Dementia Assessment Sheet for Community‐based Integrated Care System 21 Items among Chinese Community‐dwelling Older Adults

Comparison Of Prevalence And Associated Risk Factors Of Dementia, Mild Cognitive Impairment Among Elderly Between Common Communities And Nursing Homes

Adjusting Survey Response Distributions Using Multiple Imputation: A Simulation with External Validation

A Machine Learning-Based Multiple Imputation Method for the Health and Aging Brain Study–Health Disparities

Characteristics of Participants’ and Caregivers’ Influence on Non-Response in a Cross-Sectional Study of Dementia in an Older Population

Evaluation of multiple imputation to address intended and unintended missing data in case-cohort studies with a binary endpoint

The Prevalence of Mild Cognitive Impairment among Chinese People: A Meta-Analysis